Compare ClearPoint Neuro Inc (CLPT) vs Invesco S&P 500 Momentum ETF (SPMO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ClearPoint Neuro Inc vs Invesco S&P 500 Momentum ETF — how do they compare? ClearPoint Neuro Inc trades at $14.68 (market cap $454.21M), while Invesco S&P 500 Momentum ETF trades at $151.42. The key difference: Invesco S&P 500 Momentum ETF is trading nearer its 52-week high, ClearPoint Neuro Inc nearer its low. Which is the better fit depends on your goals.
| CLPT | SPMO | |
|---|---|---|
Market Cap | $454.21M | — |
Sector | Health | Broad Market / Factor |
52-Week High | $29.60 | $161.66 |
52-Week Low | $8.66 | $107.84 |
Enterprise Value | $488.79M | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ClearPoint Neuro Inc
ClearPoint Neuro provides medical devices and software for precise neurosurgical procedures. Its navigation systems allow surgeons to perform minimally invasive brain and spine surgeries with extreme accuracy.
Read more on CLPT →About Invesco S&P 500 Momentum ETF
SPMO is designed to track the investment results of the S&P 500 Momentum Index. This index measures the performance of stocks in the S&P 500 that exhibit the highest momentum, or the greatest price appreciation, over the trailing 12 months, while excluding the most recent month. By investing in these high-momentum stocks, SPMO seeks to capitalize on the historical trend that stocks with strong recent performance tend to continue that performance in the near term, offering a systematic approach to factor investing within the large-cap U.S. equity market.
Read more on SPMO →
